Category: bryostatin

Neurotrope – Alzheimer’s trial Phase 2

Neurotrope – Alzheimer’s trial Phase 2

Neurotrope misses primary endpoint in Alzheimer’s trial by Nick Paul Taylor | May 1, 2017 6:59am A phase 2 trial of Neurotrope’s Alzheimer’s disease candidate has missed its primary endpoint. The study set out to show bryostatin improved performance on a...